Monographs: Dosage forms: Specific monographs: Cycloserine capsules (Cycloserini capsulae)

Category. Antibacterial; tuberculostatic.

Storage. Cycloserine capsules should be kept in a tightly closed container.

Additional information. Strength in the current WHO Model List of Essential Medicines (EML): 250 mg. Strength in the current EML for children: 250 mg.

Requirements

Comply with the monograph for Capsules.

Definition. Cycloserine capsules contain Cycloserine. They contain not less than 90.0% and not more than 110.0% of the amount of cycloserine (C3H 6N2O2) stated on the label.

Manufacture . The manufacturing process and the product packaging are designed and controlled so as to minimize the moisture content of the capsules. They ensure that, if tested, the contents of the capsules would comply with a loss on drying limit of not more than 20 mg/g when determined by drying a suitable quantity of the contents of the capsules for 3 hours under reduced pressure (not exceeding 0.6 kPa or about 5 mm of mercury) at 60 °C.

Identity tests

  • Either tests A and B or tests B and C may be applied.

A. Carry out test A.1 or, where UV detection is not available, test A.2.

A.1 Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography using silica gel R6 as the coating substance and a mixture of 4 volumes of 1-butanol R, 1 volume of glacial acetic acid R and 2 volumes of water R as the mobile phase. Apply separately to the plate 10 µL of each of the following two solutions. For solution (A) shake a quantity of the contents of the capsules equivalent to 40 mg of cycloserine with 1 mL of water R, add 9 mL of methanol R, shake again, filter and use the filtrate. For solution (B) dissolve 20 mg of cycloserine RS in 0.5 mL of water R, add 4.5 mL of methanol R and shake. After removing the plate from the chromatographic chamber allow it to dry exhaustively in a current of air. Examine the chromatogram in ultraviolet light (254 nm).

The principal spot obtained with solution (A) corresponds in position, appearance and intensity with that obtained with solution (B).

A.2 Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography using the conditions described above under test A.1, but using silica gel R5 as the coating substance. After removing the plate from the chromatographic chamber allow it to dry in a current of air and place the plate in a chamber with iodine vapours. Examine the chromatogram in daylight.

The principal spot obtained with solution A corresponds in position, appearance and intensity with that obtained with solution B.

B. Shake a quantity of the contents of the capsules containing 10 mg of cycloserine with 100 mL of sodium hydroxide (~4 g/L) TS and filter. To 1 mL of the filtrate add 3 mL of acetic acid (~60 g/L) TS and 1 mL of a recently prepared mixture of equal volumes of a 40 mg/mL solution of sodium nitroprusside R and sodium hydroxide (~200 g/L) TS; a blue colour gradually develops.

C. See the test described under “Assay”, method A. The retention time of the principal peak in the chromatogram obtained with solution (1) is similar to that in the chromatogram obtained with solution (2).

Related substances

Carry out the test as described under 1.14.1 Chromatography, High-performance liquid chromatography using the conditions given under “Assay”, method A.

Prepare fresh solutions and perform the tests without delay.

Prepare the following solutions in mobile phase A. For solution (1) transfer a quantity of the contents of the capsules containing 100.0 mg of cycloserine into a 100 mL volumetric flask. Add about 70 mL, shake for 5 minutes, make up to volume and filter. For solution (2) dilute a suitable volume of solution (1) to obtain a concentration of 5.0 μg of cycloserine per mL. For solution (3) use a solution containing 10.0 µg of D-serine R per mL. For solution (4) dilute a suitable volume of solution (3) to obtain a concentration of 2.0 µg of D-serine R per mL. For solution (5) dilute a suitable volume of solution (1) to obtain a concentration of 50 μg of cycloserine per mL. Heat this solution carefully in a boiling water-bath for 30 minutes. For solution (6) mix 1 mL of solution (3) with 1 mL of solution (5).

Inject 50 μL of solution (6). The test is not valid unless the peak corresponding to D-serine with a relative retention time of about 0.23 with reference to cycloserine (retention time about 14 minutes) and the large degradation peak with a relative retention time of about 0.27 are baseline separated.

Inject alternatively 50 μL each of solutions (1), (2) and (4).

In the chromatogram obtained with solution (1) the following impurities, if present, are eluted at the following relative retention with reference to cycloserine: impurity B (D-serine) about 0.23, impurity C about 0.35 and impurity A about 1.8. Use the chromatogram obtained with solution (4) to identify a peak due to impurity B.

In the chromatogram obtained with solution (1):

  • the area of any peak corresponding to impurity B (D-serine) is not greater than twice the area of the principal peak in the chromatogram obtained with solution (4) (0.4%);
  • the area of any other impurity peak is not greater than twice the area of the principal peak in the chromatogram obtained with solution (2) (1.0%);
  • the sum of the areas of all impurity peaks, other than any peak corresponding to impurity B (D-serine), is not greater than six times the area of the principal peak in the chromatogram obtained with solution (2) (3.0%). Disregard any peak with an area less than 0.1 times the area of the principal peak in the chromatogram obtained with solution (2) (0.05%).

Assay

  • Either method A or method B may be applied.

A. Carry out the assay as described under 1.14.1 Chromatography, High-performance liquid chromatography using a stainless steel column (25 cm x 4.6 mm) packed with base deactivated particles of silica gel, the surface of which has been modified with chemically-bonded octadecylsilyl groups (5 μm).

The mobile phases for gradient elution consist of a mixture of mobile phase A and mobile phase B, using the following conditions:

mobile phase A: 4 volumes of acetonitrile for chromatography R, 70 volumes of a 0.02 mol/L sodium octanesulfonate R solution, 10 volumes of phosphate buffer pH 2.8 and 16 volumes of water R;

mobile phase B: 17 volumes of acetonitrile for chromatography R, 70 volumes of a 0.02 mol/L sodium octanesulfonate R solution, 10 volumes of phosphate buffer pH 2.8 and 3 volumes of water R.

Prepare the sodium octanesulfonate solution by dissolving 4.7 g of sodium octanesulfonate R in 1000 mL of water R.

Prepare the phosphate buffer pH 2.8 by dissolving 27.2 g of potassium dihydrogen phosphate R in 800 mL of water R, adjust the pH to 2.8 by adding phosphoric acid (~20 g/L) TS and dilute to 1000 mL with water R.

Time

(min)

Mobile phase A

(% v/v)

Mobile phase B

(% v/v)

Comments

0–16

100

0

Isocratic

16–18

100 to 0

0 to 100

Linear gradient

18–28

0

100

Isocratic

28–30

0 to 100

100 to 0

Return to initial composition

30–45

100

0

Re-equilibration

Prepare the following three solutions in mobile phase A. For solution (1) weigh and mix the contents of 20 capsules and transfer a quantity of the contents containing about 10 mg of cycloserine, accurately weighed, into a 100 mL volumetric flask. Add about 70 mL, shake for 5 minutes, make up to volume and filter. For solution (2) use 0.1 mg of cycloserine RS per mL.

Operate with a flow rate of 1.0 mL per minute. As a detector use an ultraviolet spectrophotometer set at a wavelength of 195 nm.

Maintain the column temperature at 45 °C.

Inject alternatively 50 µL each of solutions (1) and (2). The test is not valid unless the symmetry factor of the peak due to cycloserine is between 0.8 and 1.5.

Measure the areas of the peaks responses obtained in the chromatograms from solutions (1) and (2) and calculate the content of cycloserine (C3H 6N2O2) in the capsules, using the declared content of C3H6N2O2 in cycloserine RS.

B. Weigh and mix the contents of 20 capsules and transfer a quantity of the contents containing 0.250 g of cycloserine, accurately weighed, into a 200 mL volumetric flask. Add hydrochloric acid (0.1 mol/L) VS to volume, shake for 10 minutes and filter. Dilute 2 mL of the filtrate to 100 mL with hydrochloric acid (0.1 mol/L) VS.

Measure the absorbance (1.6) of this solution in a 1 cm layer at the maximum at about 219 nm against a solvent cell containing hydrochloric acid (0.1 mol/L) VS.

Calculate the content of cycloserine (C3H6N2O2) in the capsules, using an absorptivity value of 34.3 ( = 343).

Impurities

The impurities limited by the requirements of this monograph include those listed in the monograph for Cycloserine.

to previous sectionto next section